Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ebrantil

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Summary. Aim. To evaluate the clinical efficacy of ebrantil used in patients with resistant arterial hypertension (RAH) in Stage… Expand
2010
2010
Different bones have different blood supplies, which may influence bone healing. Therefore, elucidation of the mechanisms… Expand
2005
2005
2. The mother was hypertensive prior to pregnancy. After repeated questioning, she stated that she was on antihypertensive… Expand
  • table 1
1996
1996
Urapidil, a new alpha-blocker that peripherally antagonizes postsynaptic alpha 1 receptors and centrally causes a reduction in… Expand
1990
1990
In 10 patients on chronic haemodialysis treatment for terminal renal failure with hypertension urapidil (Ebrantil) was given in… Expand
1990
1990
In a cross-over study, the effect of 25 mg urapidil infusion (U, Ebrantil 25, Byk-Gulden, FRG) on serotonin (5HT) metabolism and… Expand
1985
1985
Urapidil (Ebrantil) is a new antihypertensive agent exerting central and peripheral action which is recognized for the treatment… Expand
1981
1981
The vasodilating effect of 6-(3-[4-(o-methoxy-phenyl)-piperazin-1-yl]-propylamino)-1,3-dimethyluracil (urapidil, Ebrantil) and… Expand
1977
1977
Compared to the changes in spontaneous behaviour of mice and rats, 6-(3-[4-(o-methoxyphenyl)-1-piperazinyl]-propyl-amino)-1,3… Expand